Detailed Information on Publication Record
2017
Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders
CAPRNDA, M., P.. KUBATKA, K. GAZDIKOVA, I. GASPAROVA, V. VALENTOVA et. al.Basic information
Original name
Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders
Authors
CAPRNDA, M. (703 Slovakia), P.. KUBATKA (703 Slovakia), K. GAZDIKOVA (703 Slovakia), I. GASPAROVA (703 Slovakia), V. VALENTOVA (703 Slovakia), N. STOLLAROVA (703 Slovakia), G. LA ROCCA (380 Italy), N. KOBYLIAK (804 Ukraine), J. DRAGASEK (703 Slovakia), I. MOZOS (642 Romania), R. PROSECKY (203 Czech Republic), D. SINISCALCO (380 Italy), D. BUSSELBERG (634 Qatar), L. RODRIGO (724 Spain) and Peter KRUŽLIAK (703 Slovakia, guarantor, belonging to the institution)
Edition
BIOMEDICINE & PHARMACOTHERAPY, PARIS, ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 2017, 0753-3322
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30104 Pharmacology and pharmacy
Country of publisher
France
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 3.457
RIV identification code
RIV/00216224:14110/17:00098636
Organization unit
Faculty of Medicine
UT WoS
000406399900008
Keywords in English
Stem cell therapy; Neurodegenerative disorders; Regenerative medicine
Tags
Tags
International impact, Reviewed
Změněno: 18/3/2018 23:02, Soňa Böhmová
Abstract
V originále
Stem cells have the capability of self-renewal and can differentiate into different cell types that might be used in regenerative medicine. Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) currently lack effective treatments. Although stem cell therapy is still on the way from bench to bedside, we consider that it might provide new hope for patients suffering with neurodegenerative diseases. In this article, we will give an overview of recent studies on the potential therapeutic use of mesenchymal stem cells (MSCs), neural stem cells (NSCs), embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and perinatal stem cells to neurodegenerative disorders and we will describe their immunomodulatory mechanisms of action in specific therapeutic modalities. (C) 2017 Elsevier Masson SAS. All rights reserved.